Celularity (CELU) Interest Expenses (2019 - 2025)
Celularity (CELU) posted quarterly Interest Expenses of $4.2 million for Q4 2025, up 196.68% year-over-year from $1.4 million in Q4 2024, and up 13.4% quarter-over-quarter from $3.7 million in Q3 2025.
Celularity (CELU) Interest Expenses (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Interest Expenses for 7 consecutive years, with $4.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Expenses rose 196.68% year-over-year to $4.2 million; the TTM figure through Dec 2025 stood at -$1.3 million (up 71.96% YoY), while the FY2025 annual figure was $10.9 million, up 48.44% from the prior year.
- Interest Expenses improved to $4.2 million in Q4 2025 per CELU's latest filing, from $3.7 million in the prior quarter.
- Across five years, Interest Expenses topped out at $99.7 million in Q3 2024 and bottomed at -$4.3 million in Q4 2024.
- Historically, Interest Expenses has averaged $30.0 million across 5 years, with a median of $3.9 million in 2025.
- Annual changes were most pronounced in 2021 — Interest Expenses soared 13620.82% — and 2023, when it tumbled 431.31%.
- Celularity's Interest Expenses stood at -$2.3 million in 2021, then jumped by 131.29% to $709000.0 in 2022, then sank by 431.31% to -$2.3 million in 2023, then plunged by 83.4% to -$4.3 million in 2024, then soared by 196.68% to $4.2 million in 2025.
- Business Quant data shows CELU's Interest Expenses at $4.2 million in Q4 2025, $3.7 million in Q3 2025, and $70.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 93.62 Mn |
| 10 | Celularity | 21.75 Mn | 15.58 Mn | -3.27 Mn | 897,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.17 Mn |
| Dec 31, 2025 | 4.17 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 70.38 Mn |
| Jun 30, 2025 | 70.38 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Dec 31, 2024 | -4.31 Mn |
| Dec 31, 2024 | -4.31 Mn |
| Sep 30, 2024 | 99.66 Mn |
| Sep 30, 2024 | 99.66 Mn |
| Jun 30, 2024 | 74.15 Mn |
| Jun 30, 2024 | 74.15 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | -2.35 Mn |
| Dec 31, 2023 | -2.35 Mn |
| Sep 30, 2023 | 76.95 Mn |
| Sep 30, 2023 | 76.95 Mn |